Company: INDP
Filing Date: 2025-02-12
Form Type: S-1
Source: 0001493152-25-006068
Chunk: 3

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-02-12
Form: S-1
Chunk 3
---
 last reported sale price of our common stock on the Nasdaq Capital Market was $0.8053 per share.

Investing in our securities involves risks. See the section entitled “Risk Factors” included in into the prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is February , 2025</div>

<div align='center'>TABLE OF CONTENTS</div>

|                                                                                       | Page |
| ABOUT THIS PROSPECTUS                                                                 |    1 |
| PROSPECTUS SUMMARY                                                                    |    2 |
| THE OFFERING                                                                          |    6 |
| RISK FACTORS                                                                          |    8 |
| SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS                                     |   46 |
| USE OF PROCEEDS                                                                       |   47 |
| DIVIDEND POLICY                                                                       |   48 |
| Management’s Discussion and Analysis of Financial Condition and Results of Operations |   49 |
| BUSINESS                                                                              |   58 |
| MANAGEMENT                                                                            |   77 |
| EXECUTIVE COMPENSATION                                                                |   84 |
| Certain Relationships and Related Party Transactions                                  |   95 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT                        |   96 |
| SELLING STOCKHOLDER                                                                   |   98 |
| DESCRIPTION OF SECURITIES                                                             |   99 |
| PLAN OF DISTRIBUTION                                                                  |  104 |
| LEGAL MATTERS                                                                         |  105 |
| EXPERTS                                                                               |  105 |
| WHERE YOU CAN FIND MORE INFORMATION                                                   |  106 |

| i |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the “SEC”). As permitted by the rules and regulations of the SEC, the registration statement filed by us includes additional information not contained in this prospectus. You may read the registration statement and the other reports we file with the SEC at the SEC’s website or its offices described below under the heading “Where You Can Find More Information”.

You should rely only on the information contained in this prospectus. We have not, and the selling stockholder has not, authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should